As President Trump signed the “Right to Try Act” into law Wednesday afternoon, 8-year-old Jordan McLinn of Indiana bashfully attempted to hug the president, who missed his first few tries. After a third attempt, the two embraced.
US President Donald Trump hugs Jordan McLinn, who suffers from Duchenne Muscular Dystrophy (DMD), before signing the Right To Try Act, which allows terminally ill patients to seek treatment using drugs that have not yet been approved, at the White House in Washington, DC, on May 30, 2018. (Photo by NICHOLAS KAMM / AFP) (Photo credit should read NICHOLAS KAMM/AFP/Getty Images)
Nicholas Kamm / AFP/Getty Images
McLinn has Duchenne muscular dystrophy, a degenerative genetic disease. Symptoms first appear at 3 to 5 years of age, and children afflicted with DMD are likely to be wheelchair-bound by the age of 12. Life expectancy was until recently very short — many did not survive beyond their teen years, according to the DMD website. But advances in care have extended life expectancy into the early 30s and longer in recent years. The legislation Mr. Trump signed Thursday could give McLinn access to experimental drugs and treatments not yet approved by the Food and Drug Administration (FDA).
“There are no options, but now you have hope. You really have hope,” Mr. Trump said during the signing.
Mr. Trump gave McLinn one of the signing pens, squeezed his cheeks and made a joked about getting the pen back later.
Jordan, a 5-year-old who is the face of Indiana’s “right to try” bill, with Indiana Gov. Mike Pence
COURTESY OF MCLINN FAMILY
The 8-year-old is no stranger to politics. When the “Right to Try” legislation came to the House in March 2018, Republican representatives brought McLinn and other terminally ill patients to the House chamber. He sat next to Rep. Greg Walden, R-Ore., while the House discussed the potentially life-saving bill.
McLinn also appeared two years ago with then Indiana Gov. Mike Pence, now vice president, as he signed nearly identical Right-to-Try legislation specific to their home state. That bill passed unanimously in the state legislature.
While many patients and families in positions similar to that of McLinn’s support the chance to try not-yet-FDA-approved drugs and treatments, some patient groups and medical advocates are concerned that the new law could actually make it more difficult for new drugs to receive FDA approval.
US President Donald Trump speaks to a young boy before signing the “Right To Try Act”, which allows terminally ill patients to seek treatment using drugs that have not yet been approved, at the White House in Washington, DC, on May 30, 2018. (Photo by Nicholas Kamm / AFP) (Photo credit should read NICHOLAS KAMM/AFP/Getty Images)
Nicholas Kamm / AFP/Getty Images
© 2018 CBS Interactive Inc. All Rights Reserved.
